JP2022546572A5 - - Google Patents
Info
- Publication number
- JP2022546572A5 JP2022546572A5 JP2022514481A JP2022514481A JP2022546572A5 JP 2022546572 A5 JP2022546572 A5 JP 2022546572A5 JP 2022514481 A JP2022514481 A JP 2022514481A JP 2022514481 A JP2022514481 A JP 2022514481A JP 2022546572 A5 JP2022546572 A5 JP 2022546572A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antibody
- antigen
- immunoglobulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962896415P | 2019-09-05 | 2019-09-05 | |
| US62/896,415 | 2019-09-05 | ||
| PCT/US2020/049377 WO2021046331A1 (en) | 2019-09-05 | 2020-09-04 | Anti-steap1 antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546572A JP2022546572A (ja) | 2022-11-04 |
| JP2022546572A5 true JP2022546572A5 (https=) | 2023-09-11 |
| JP7805287B2 JP7805287B2 (ja) | 2026-01-23 |
Family
ID=74853055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514481A Active JP7805287B2 (ja) | 2019-09-05 | 2020-09-04 | 抗ｓｔｅａｐ１抗体およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220348686A1 (https=) |
| EP (1) | EP4025609A4 (https=) |
| JP (1) | JP7805287B2 (https=) |
| KR (1) | KR20220057575A (https=) |
| CN (1) | CN114929743B (https=) |
| AU (1) | AU2020343652A1 (https=) |
| CA (1) | CA3150149A1 (https=) |
| IL (1) | IL291027A (https=) |
| WO (1) | WO2021046331A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022373303A1 (en) * | 2021-10-20 | 2024-05-09 | Memorial Hospital For Cancer And Allied Diseases | Anti-tshr multi-specific antibodies and uses thereof |
| GB202208119D0 (en) * | 2022-06-01 | 2022-07-13 | Univ Oslo Hf | Anti-steap1 car |
| TW202417504A (zh) * | 2022-07-22 | 2024-05-01 | 美商建南德克公司 | 抗ｓｔｅａｐ１抗原結合分子及其用途 |
| CA3264030A1 (en) * | 2022-08-04 | 2024-02-08 | Memorial Hospital For Cancer And Allied Diseases | Anti-CD24 antibodies and their uses |
| AU2024243972A1 (en) * | 2023-04-06 | 2025-10-23 | Memorial Hospital For Cancer And Allied Diseases | Il-10 receptor antibodies and methods of use thereof |
| TW202515613A (zh) * | 2023-08-21 | 2025-04-16 | 德商安美基研究（慕尼黑）公司 | 用於治療前列腺癌之方法 |
| TW202513554A (zh) * | 2023-08-21 | 2025-04-01 | 德商安美基研究（慕尼黑）公司 | 用於治療前列腺癌之組合療法 |
| WO2025128807A1 (en) * | 2023-12-13 | 2025-06-19 | Amgen Inc. | Radiolabeled compounds for the detection of steap1 |
| CN119113151B (zh) * | 2024-08-01 | 2025-11-18 | 华中科技大学同济医学院附属同济医院 | 一种前列腺癌特异性细胞外囊泡荧光探针及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004319915B9 (en) * | 2004-04-22 | 2011-12-22 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| BRPI0717638A2 (pt) * | 2006-10-27 | 2013-11-12 | Genentech Inc | Anticorpors e imunoconjugados e usos para os mesmos |
| UA94628C2 (ru) * | 2006-10-27 | 2011-05-25 | Дженентек, Инк. | Гуманизированное моноклональное антитело, которое связывается с steap-1, и его применение |
| GB0917044D0 (en) * | 2009-09-29 | 2009-11-18 | Cytoguide As | Agents, uses and methods |
| NZ701208A (en) * | 2010-06-03 | 2016-05-27 | Genentech Inc | Immuno-pet imaging of antibodies and immunoconjugates and uses thereof |
| MX350807B (es) * | 2011-11-29 | 2017-09-20 | Genentech Inc | Composiciones y metodos para el analisis de cancer de prostata. |
| KR101911438B1 (ko) * | 2012-10-31 | 2018-10-24 | 삼성전자주식회사 | 이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법 |
| EP3096797A1 (en) * | 2014-01-24 | 2016-11-30 | F. Hoffmann-La Roche AG | Methods of using anti-steap1 antibodies and immunoconjugates |
| SG11201701128YA (en) * | 2014-09-12 | 2017-03-30 | Genentech Inc | Cysteine engineered antibodies and conjugates |
| ES3007999T3 (en) * | 2015-04-21 | 2025-03-21 | Genentech Inc | Compositions and methods for prostate cancer analysis |
| AU2016274767B2 (en) * | 2015-06-09 | 2022-05-19 | Eureka Therapeutics, Inc. | T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA |
| JP2018533930A (ja) * | 2015-10-02 | 2018-11-22 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性ｔ細胞活性化抗原結合分子 |
| US11046768B2 (en) * | 2017-01-27 | 2021-06-29 | Memorial Sloan Kettering Cancer Center | Bispecific HER2 and CD3 binding molecules |
| MX2019011769A (es) * | 2017-04-03 | 2019-11-07 | Hoffmann La Roche | Anticuerpos que se unen a steap-1. |
| US12084514B2 (en) * | 2017-12-04 | 2024-09-10 | The Board Of Regents Of The University Of Oklahoma | Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof |
| EP3938400B1 (en) * | 2019-03-11 | 2025-07-30 | Memorial Sloan Kettering Cancer Center | Cd22 antibodies and methods of using the same |
-
2020
- 2020-09-04 WO PCT/US2020/049377 patent/WO2021046331A1/en not_active Ceased
- 2020-09-04 KR KR1020227011015A patent/KR20220057575A/ko active Pending
- 2020-09-04 US US17/640,598 patent/US20220348686A1/en active Pending
- 2020-09-04 EP EP20860238.3A patent/EP4025609A4/en active Pending
- 2020-09-04 CA CA3150149A patent/CA3150149A1/en active Pending
- 2020-09-04 JP JP2022514481A patent/JP7805287B2/ja active Active
- 2020-09-04 CN CN202080076671.XA patent/CN114929743B/zh active Active
- 2020-09-04 AU AU2020343652A patent/AU2020343652A1/en active Pending
-
2022
- 2022-03-01 IL IL291027A patent/IL291027A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022546572A5 (https=) | ||
| JP2022538117A5 (https=) | ||
| JP2023523584A5 (https=) | ||
| JP2022525435A5 (https=) | ||
| Sharkey et al. | Cancer radioimmunotherapy | |
| Milenic et al. | Antibody-targeted radiation cancer therapy | |
| Kenanova et al. | Tailoring antibodies for radionuclide delivery | |
| IL273484B1 (en) | A33 antibody compositions and methods of using the same in radioimmunotherapy | |
| US11427648B2 (en) | Anti-CD146 antibodies and uses thereof | |
| JP2020523029A5 (https=) | ||
| Kraeber-Bodéré et al. | A pretargeting system for tumor PET imaging and radioimmunotherapy | |
| JP2023537002A5 (https=) | ||
| Chester et al. | Engineering antibodies for clinical applications in cancer | |
| JP2024530166A5 (https=) | ||
| Navarro-Teulon et al. | General overview of radioimmunotherapy of solid tumors | |
| Kenanova et al. | Radioiodinated versus radiometal-labeled anti–carcinoembryonic antigen single-chain Fv-Fc antibody fragments: Optimal pharmacokinetics for therapy | |
| Bailly et al. | Pretargeting for imaging and therapy in oncological nuclear medicine | |
| US8198411B2 (en) | Anti-mullerian inhibiting substance type II receptor (MISIIR) immunoconjugates to detect and treat cancer | |
| Reilly | Monoclonal antibody and peptide-targeted radiotherapy of cancer | |
| De Pauw et al. | Current status and future expectations of nanobodies in oncology trials | |
| Oriuchi et al. | Current status of cancer therapy with radiolabeled monoclonal antibody | |
| JP2021517816A5 (https=) | ||
| CA3062335A1 (en) | Use of anti-b7h3 antibodies for treating cancer in the central nervous system | |
| JP2006507803A (ja) | モノクローナル抗体ｐａｍ４ならびに膵臓癌の診断および治療のためのその使用 | |
| JP2020534017A5 (https=) |